Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
257
pubmed:dateCreated
1984-2-24
pubmed:abstractText
A group of 29 hypertensive patients were studied for side effects of acebutolol. An antinuclear antibody titre of >/=1/64 developed in 23 per cent of patients during a 12-month course of treatment. Full ophthalmic examination before and after the treatment period showed a statistically significant increase in tear secretion at one year. One patient had a slight worsening of her psoriasis. No patients developed any symptoms or signs of oculomucocutaneous syndrome (OMCS) or systemic lupus erythematosus (SLE).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-11032, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-1125623, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-125135, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-308936, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-4145853, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-4965427, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-6103797, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-6104977, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-6122487, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-6973944, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-7010591, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-7442350, http://linkedlifedata.com/resource/pubmed/commentcorrection/6606705-87291
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0035-8797
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
779-82
pubmed:dateRevised
2010-6-22
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Ocular, systemic and antinuclear antibody changes with acebutolol.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't